{
    "Trade/Device Name(s)": [
        "NMR LipoProfile\u00ae test",
        "NMR Profiler"
    ],
    "Submitter Information": "LipoScience, Inc.",
    "510(k) Number": "K111516",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063841"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "MRR",
        "LBS",
        "CDT",
        "JJY",
        "JIT"
    ],
    "Summary Letter Date": "September 27, 2011",
    "Summary Letter Received Date": "August 15, 2011",
    "Submission Date": "August 11, 2011",
    "Regulation Number(s)": [
        "21 CFR 862.1475",
        "21 CFR 862.1175",
        "21 CFR 862.1705",
        "21 CFR 862.1660",
        "21 CFR 862.1150"
    ],
    "Regulation Name(s)": [
        "Lipoprotein Test System",
        "Cholesterol Test System",
        "Triglyceride Test System",
        "Quality Control Material",
        "Calibrator"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "LDL particle number (LDL-P)",
        "HDL cholesterol (HDL-C)",
        "Triglycerides"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "NMR LipoTube",
        "Plain red-top tube",
        "EDTA tube",
        "Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "NMR Profiler (400 MHz proton NMR spectrometer)",
        "Automated NMR spectrometer"
    ],
    "Method(s)/Technology(ies)": [
        "Nuclear magnetic resonance (NMR) spectroscopy",
        "Signal deconvolution analysis"
    ],
    "Methodologies": [
        "Particle quantification",
        "Spectral deconvolution"
    ],
    "Submission Type(s)": [
        "Test",
        "Analyzer",
        "Instrument",
        "Software",
        "Control",
        "Calibrator",
        "Quality control material",
        "Reagent",
        "Reference standard",
        "Diluent",
        "Wash solution"
    ],
    "Document Summary": "FDA 510(k) summary for NMR LipoProfile test and NMR Profiler for quantification of LDL particle number, HDL cholesterol, and triglycerides using NMR spectroscopy in serum and plasma",
    "Indications for Use Summary": "Quantifies LDL particle number, HDL cholesterol, and triglycerides in human serum and plasma using NMR spectroscopy to aid management of lipoprotein disorders associated with cardiovascular disease, used alongside other lipid measurements and clinical evaluation",
    "fda_folder": "Clinical Chemistry"
}